Cancer Drug News Issue - Global Expansion of Portrazza will Aid in Supporting Eli Lilly's Lung Cancer Franchise - Research and Markets

DUBLIN--()--Research and Markets has announced the addition of the "Cancer Drug News Issue 670" report to their offering.

The global expansion of Portrazza will aid in supporting Eli Lilly's lung cancer franchise, but a number of market factors will serve to cap sales well below blockbuster levels. Portrazza is indicative of Eli Lilly's current new product portfolio, which will serve to effectively maintain revenues but not provide high growth levels. The company's innovative pipeline and exploration of novel development routes will serve to bring back notable growth in the long-term.

Key Topics Covered:

  1. Portrazza To Be Modest Contributor To Lilly Revenue Maintenance Haematological Cancer
  2. Gazyva FDA-Approved For Previously Treated Follicular Lymphoma Population
  3. Ixazomib Granted Orphan Drug Designation In Japan
  4. CHMP Recommends Acalabrutinib As Orphan Medicinal Drug For Lymphomas
  5. Asterias Concludes End-of-Phase II Meeting With FDA For AST-VAC1 Lung Cancer
  6. Peregrine Terminates Bavituximab Phase III SUNRISE Trial
  7. First Patients Treated In Tedopi Phase III Advanced NSCLC Trial Genito-Urinary Cancer
  8. FDA Accepts sNDA For Xtandi In MCRPCA General Developments
  9. FDA Approves Novartis' Afinitor For Non-Functional NETs
  10. CHMP Recommends Opdivo And Lonsurf Approvals
  11. Unmet Medical Need From Pancreatic Cancer To Grow
  12. Growing Cancer Burden To Attract Drugmakers
  13. Myriad's Diversification Drive Builds Strong Portfolio Corporate Activity
  14. OSE Pharma/Effimune Enter Merger Agreement To Form Immunotherapy Company

For more information visit http://www.researchandmarkets.com/research/2xzmrx/cancer_drug_news

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector: Oncology Drugs

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector: Oncology Drugs